Publications by authors named "Satoshi Yanagida"

Claim this Profile
M
Molecular and pathological analysis of and promoter mutations in adult-type granulosa cell tumors of the ovary: a study of 64 Japanese patients.
Satoshi Yanagida, Yuichi Shoburu, Takako Kiyokawa, Masami Iwamoto, Misato Saito

J Gynecol Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two Cases of Chronic Tubular Necrosis Presenting as Fanconi Syndrome Induced by Red Yeast Rice Choleste-Help.
Kanako Mita, Shunsuke Takahashi, Satoshi Yanagida, Akihiro Aoyama, Takayuki Shiraishi

Diagnostics (Basel)· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer: final results of a multicenter phase 2 study.
Daisuke Aoki, Tsutomu Tabata, Satoshi Yanagida, Toshiaki Nakamura, Eiji Kondo

J Gynecol Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validate robot-assisted total laparoscopic hysterectomy with four equally-spaced ports without an assistant port.
Hiroe Ito, Wakiko Shimomai, Yoshihiko Matsuzaki, Jiro Suzuki, Kako Kuroiwa, Satoshi Yanagida

J Robot Surg· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.
Kimihiko Ito, Mio Nakagawa, Mototsugu Shimokawa, Kensuke Hori, Lena Tashima, Satoshi Yanagida

Anticancer Drugs· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paclitaxel sensitizes homologous recombination-proficient ovarian cancer cells to PARP inhibitor via the CDK1/BRCA1 pathway.
Nozomu Yanaihara, Yuki Yoshino, Daito Noguchi, Junya Tabata, Masataka Takenaka, Satoshi Yanagida

Gynecol Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single assistant versus dual assistant robotic surgery for robot-assisted laparoscopic hysterectomy using da Vinci Xi or X.
Hiroe Ito, Satoshi Yanagida, Yoichiro Toyonaga, Hideyuki Yamashita, Makoto Ohori

Int J Med Robot· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-thinking the prognostic significance of positive peritoneal cytology in endometrial cancer.
Masataka Takenaka, Misato Kamii, Yasushi Iida, Nozomu Yanaihara, Jiro Suzuki, Satoshi Yanagida

Gynecol Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-6 as an enhancer of anti-angiogenic therapy for ovarian clear cell carcinoma.
Toshiyuki Seki, Nozomu Yanaihara, Jason Solomon Shapiro, Misato Saito, Junya Tabata, Satoshi Yanagida

Sci Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 single-arm study on the efficacy and safety of niraparib in Japanese patients with heavily pretreated, homologous recombination-deficient ovarian cancer.
Aikou Okamoto, Eiji Kondo, Toshiaki Nakamura, Satoshi Yanagida, Junzo Hamanishi

J Gynecol Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: TERT promoter mutation in adult granulosa cell tumor of the ovary.
Jessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, Geraldine Aubert, Anniina E M Färkkilä, Satoshi Yanagida

Mod Pathol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TERT promoter mutation in adult granulosa cell tumor of the ovary.
Jessica A Pilsworth, Dawn R Cochrane, Zhouchunyang Xia, Geraldine Aubert, Anniina E M Färkkilä, Satoshi Yanagida

Mod Pathol· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The Review].
Satoshi Yanagida

Nihon Hoshasen Gijutsu Gakkai Zasshi· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.
Satoshi Yanagida, Michael S Anglesio, Tayyebeh M Nazeran, Amy Lum, Momoko Inoue

PLoS One· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic consequences of aberrant DNA repair mechanisms stratify ovarian cancer histotypes.
Yi Kan Wang, Ali Bashashati, Michael S Anglesio, Dawn R Cochrane, Diljot S Grewal, Satoshi Yanagida

Nat Genet· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stepwise increase of MIB-1 index in frequently relapsed malignant peritoneal mesothelioma.
Seiji Isonishi, Daito Noguchi, Ryosuke Saito, Satoshi Yanagida, Masaharu Fukunaga

Int Cancer Conf J· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatic copy number alterations associated with Japanese or endometriosis in ovarian clear cell adenocarcinoma.
Aikou Okamoto, Jalid Sehouli, Nozomu Yanaihara, Yukihiro Hirata, Ioana Braicu, Satoshi Yanagida

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of dienogest over 53 weeks for the treatment of endometriosis.
Kouhei Sugimoto, Chie Nagata, Hiroshi Hayashi, Satoshi Yanagida, Aikou Okamoto

J Obstet Gynaecol Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASBEL, an ANA/BTG3 antisense transcript required for tumorigenicity of ovarian carcinoma.
Satoshi Yanagida, Kenzui Taniue, Hironobu Sugimasa, Emiko Nasu, Yasuko Takeda

Sci Rep· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cancer stem cell marker CD133 interacts with plakoglobin and controls desmoglein-2 protein levels.
Ryo Koyama-Nasu, Rina Takahashi, Satoshi Yanagida, Yukiko Nasu-Nishimura, Masaaki Oyama

PLoS One· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular genetic analysis of nongestational choriocarcinoma in a postmenopausal woman: a case report and literature review.
Yukihiro Hirata, Nozomu Yanaihara, Satoshi Yanagida, Kenji Fukui, Kimiharu Iwadate

Int J Gynecol Pathol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The general rules for clinical and pathological management of trophoblastic diseases--2011, the 3rd edition].
Tadao Tanaka, Satoshi Yanagida, Nozomu Yanaihara

Nihon Rinsho· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors of treatment discontinuation due to uterine bleeding in adenomyosis patients treated with dienogest.
Chie Nagata, Satoshi Yanagida, Aikou Okamoto, Asuka Morikawa, Kohei Sugimoto

J Obstet Gynaecol Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Molecular genetic of gynecological cancer].
Nozomu Yanaihara, Aikou Okamoto, Satoshi Yanagida, Kazunori Ochiai, Tadao Tanaka

Nihon Rinsho· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis